Diagnostic and prognostic utility of cardiac troponin in post-cardiac arrest care

Vijay Agusala, Rohan Khera, Daniel Cheeran, Purav Mody, Pranitha P. Reddy, Mark S. Link

Research output: Contribution to journalArticle

Abstract

Background: Cardiac troponin is routinely tested in the post-cardiac arrest setting, but its utility in identifying ischaemic aetiology and predicting left ventricular systolic dysfunction (LVSD) and survival is not known. Methods: In a retrospective single center registry, we identified 145 consecutive patients who had achieved return of spontaneous circulation after cardiac arrest and had undergone serial cardiac troponin T (cTnT) testing, echocardiogram, and expert adjudication of aetiology. Initial and peak cTnT were evaluated for assessing ischaemic aetiology, LVSD, and survival to discharge using area under the receiver operating characteristic curve (AUROC). Results: Mean age was 61 ± 14 years and 71% were men. Of the 145 arrests, 19% had an ischaemic aetiology, 68% had LVSD post-arrest, and 55% survived to discharge. All patients had a positive initial cTnT at 0.01 ng/mL (clinical cut-off). Even at higher cut-offs of 10×, 100× and 1000×, initial cTnT performed poorly (AUROC 0.57, 0.56, and 0.56) and peak cTnT performed modestly (AUROC 0.55, 0.61, and 0.62) as diagnostic tests for ischaemic aetiology. Similarly, even at higher cut-offs, initial (AUROC 0.60, 0.62, 0.55) and peak (AUROC 0.57, 0.61, and 0.62) cTnT performed poorly to modestly at predicting LVSD. The test performed poorly for predicting survival to discharge (AUROC for all <0.6). Conclusions: At both current and several-fold higher thresholds, cTnT does not perform sufficiently well to guide clinical decision-making or predict patient outcomes. Routine post-cardiac arrest testing of cTnT should be reevaluated.

Original languageEnglish (US)
Pages (from-to)69-72
Number of pages4
JournalResuscitation
Volume141
DOIs
StatePublished - Aug 1 2019

Fingerprint

Troponin T
Troponin
Heart Arrest
ROC Curve
Left Ventricular Dysfunction
Survival
Routine Diagnostic Tests
Registries

Keywords

  • Cardiac ischaemia
  • Cardiac troponin T
  • Left ventricular
  • Post cardiac arrest
  • Survival
  • systolic dysfunction

ASJC Scopus subject areas

  • Emergency Medicine
  • Emergency
  • Cardiology and Cardiovascular Medicine

Cite this

Diagnostic and prognostic utility of cardiac troponin in post-cardiac arrest care. / Agusala, Vijay; Khera, Rohan; Cheeran, Daniel; Mody, Purav; Reddy, Pranitha P.; Link, Mark S.

In: Resuscitation, Vol. 141, 01.08.2019, p. 69-72.

Research output: Contribution to journalArticle

Agusala, Vijay ; Khera, Rohan ; Cheeran, Daniel ; Mody, Purav ; Reddy, Pranitha P. ; Link, Mark S. / Diagnostic and prognostic utility of cardiac troponin in post-cardiac arrest care. In: Resuscitation. 2019 ; Vol. 141. pp. 69-72.
@article{b526929cfcdd44adac578eb2bb9b2199,
title = "Diagnostic and prognostic utility of cardiac troponin in post-cardiac arrest care",
abstract = "Background: Cardiac troponin is routinely tested in the post-cardiac arrest setting, but its utility in identifying ischaemic aetiology and predicting left ventricular systolic dysfunction (LVSD) and survival is not known. Methods: In a retrospective single center registry, we identified 145 consecutive patients who had achieved return of spontaneous circulation after cardiac arrest and had undergone serial cardiac troponin T (cTnT) testing, echocardiogram, and expert adjudication of aetiology. Initial and peak cTnT were evaluated for assessing ischaemic aetiology, LVSD, and survival to discharge using area under the receiver operating characteristic curve (AUROC). Results: Mean age was 61 ± 14 years and 71{\%} were men. Of the 145 arrests, 19{\%} had an ischaemic aetiology, 68{\%} had LVSD post-arrest, and 55{\%} survived to discharge. All patients had a positive initial cTnT at 0.01 ng/mL (clinical cut-off). Even at higher cut-offs of 10×, 100× and 1000×, initial cTnT performed poorly (AUROC 0.57, 0.56, and 0.56) and peak cTnT performed modestly (AUROC 0.55, 0.61, and 0.62) as diagnostic tests for ischaemic aetiology. Similarly, even at higher cut-offs, initial (AUROC 0.60, 0.62, 0.55) and peak (AUROC 0.57, 0.61, and 0.62) cTnT performed poorly to modestly at predicting LVSD. The test performed poorly for predicting survival to discharge (AUROC for all <0.6). Conclusions: At both current and several-fold higher thresholds, cTnT does not perform sufficiently well to guide clinical decision-making or predict patient outcomes. Routine post-cardiac arrest testing of cTnT should be reevaluated.",
keywords = "Cardiac ischaemia, Cardiac troponin T, Left ventricular, Post cardiac arrest, Survival, systolic dysfunction",
author = "Vijay Agusala and Rohan Khera and Daniel Cheeran and Purav Mody and Reddy, {Pranitha P.} and Link, {Mark S.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.resuscitation.2019.06.004",
language = "English (US)",
volume = "141",
pages = "69--72",
journal = "Resuscitation",
issn = "0300-9572",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Diagnostic and prognostic utility of cardiac troponin in post-cardiac arrest care

AU - Agusala, Vijay

AU - Khera, Rohan

AU - Cheeran, Daniel

AU - Mody, Purav

AU - Reddy, Pranitha P.

AU - Link, Mark S.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Background: Cardiac troponin is routinely tested in the post-cardiac arrest setting, but its utility in identifying ischaemic aetiology and predicting left ventricular systolic dysfunction (LVSD) and survival is not known. Methods: In a retrospective single center registry, we identified 145 consecutive patients who had achieved return of spontaneous circulation after cardiac arrest and had undergone serial cardiac troponin T (cTnT) testing, echocardiogram, and expert adjudication of aetiology. Initial and peak cTnT were evaluated for assessing ischaemic aetiology, LVSD, and survival to discharge using area under the receiver operating characteristic curve (AUROC). Results: Mean age was 61 ± 14 years and 71% were men. Of the 145 arrests, 19% had an ischaemic aetiology, 68% had LVSD post-arrest, and 55% survived to discharge. All patients had a positive initial cTnT at 0.01 ng/mL (clinical cut-off). Even at higher cut-offs of 10×, 100× and 1000×, initial cTnT performed poorly (AUROC 0.57, 0.56, and 0.56) and peak cTnT performed modestly (AUROC 0.55, 0.61, and 0.62) as diagnostic tests for ischaemic aetiology. Similarly, even at higher cut-offs, initial (AUROC 0.60, 0.62, 0.55) and peak (AUROC 0.57, 0.61, and 0.62) cTnT performed poorly to modestly at predicting LVSD. The test performed poorly for predicting survival to discharge (AUROC for all <0.6). Conclusions: At both current and several-fold higher thresholds, cTnT does not perform sufficiently well to guide clinical decision-making or predict patient outcomes. Routine post-cardiac arrest testing of cTnT should be reevaluated.

AB - Background: Cardiac troponin is routinely tested in the post-cardiac arrest setting, but its utility in identifying ischaemic aetiology and predicting left ventricular systolic dysfunction (LVSD) and survival is not known. Methods: In a retrospective single center registry, we identified 145 consecutive patients who had achieved return of spontaneous circulation after cardiac arrest and had undergone serial cardiac troponin T (cTnT) testing, echocardiogram, and expert adjudication of aetiology. Initial and peak cTnT were evaluated for assessing ischaemic aetiology, LVSD, and survival to discharge using area under the receiver operating characteristic curve (AUROC). Results: Mean age was 61 ± 14 years and 71% were men. Of the 145 arrests, 19% had an ischaemic aetiology, 68% had LVSD post-arrest, and 55% survived to discharge. All patients had a positive initial cTnT at 0.01 ng/mL (clinical cut-off). Even at higher cut-offs of 10×, 100× and 1000×, initial cTnT performed poorly (AUROC 0.57, 0.56, and 0.56) and peak cTnT performed modestly (AUROC 0.55, 0.61, and 0.62) as diagnostic tests for ischaemic aetiology. Similarly, even at higher cut-offs, initial (AUROC 0.60, 0.62, 0.55) and peak (AUROC 0.57, 0.61, and 0.62) cTnT performed poorly to modestly at predicting LVSD. The test performed poorly for predicting survival to discharge (AUROC for all <0.6). Conclusions: At both current and several-fold higher thresholds, cTnT does not perform sufficiently well to guide clinical decision-making or predict patient outcomes. Routine post-cardiac arrest testing of cTnT should be reevaluated.

KW - Cardiac ischaemia

KW - Cardiac troponin T

KW - Left ventricular

KW - Post cardiac arrest

KW - Survival

KW - systolic dysfunction

UR - http://www.scopus.com/inward/record.url?scp=85067401338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067401338&partnerID=8YFLogxK

U2 - 10.1016/j.resuscitation.2019.06.004

DO - 10.1016/j.resuscitation.2019.06.004

M3 - Article

C2 - 31201884

AN - SCOPUS:85067401338

VL - 141

SP - 69

EP - 72

JO - Resuscitation

JF - Resuscitation

SN - 0300-9572

ER -